- Home
- XAIR vs CRIS Comparison
XAIR vs CRIS Comparison
Compare XAIR & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- CRIS
- Stock Information
- Founded
- XAIR 2011
- CRIS 2000
- Country
- XAIR United States
- CRIS United States
- Employees
- XAIR N/A
- CRIS N/A
- Industry
- XAIR Medical/Dental Instruments
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XAIR Health Care
- CRIS Health Care
- Exchange
- XAIR Nasdaq
- CRIS Nasdaq
- Market Cap
- XAIR 27.7M
- CRIS 32.8M
- IPO Year
- XAIR N/A
- CRIS 2000
- Fundamental
- Price
- XAIR $0.35
- CRIS $3.10
- Analyst Decision
- XAIR Strong Buy
- CRIS Strong Buy
- Analyst Count
- XAIR 4
- CRIS 3
- Target Price
- XAIR $3.67
- CRIS $23.00
- AVG Volume (30 Days)
- XAIR 1.4M
- CRIS 28.8K
- Earning Date
- XAIR 02-10-2025
- CRIS 02-25-2025
- Dividend Yield
- XAIR N/A
- CRIS N/A
- EPS Growth
- XAIR N/A
- CRIS N/A
- EPS
- XAIR N/A
- CRIS N/A
- Revenue
- XAIR $3,023,000.00
- CRIS $10,259,000.00
- Revenue This Year
- XAIR $244.61
- CRIS N/A
- Revenue Next Year
- XAIR $258.76
- CRIS N/A
- P/E Ratio
- XAIR N/A
- CRIS N/A
- Revenue Growth
- XAIR 338.75
- CRIS 0.44
- 52 Week Low
- XAIR $0.30
- CRIS $2.86
- 52 Week High
- XAIR $2.11
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- XAIR 41.74
- CRIS 41.55
- Support Level
- XAIR $0.34
- CRIS $3.10
- Resistance Level
- XAIR $0.40
- CRIS $3.32
- Average True Range (ATR)
- XAIR 0.05
- CRIS 0.18
- MACD
- XAIR -0.00
- CRIS -0.01
- Stochastic Oscillator
- XAIR 10.21
- CRIS 9.62
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.